Skip to content

Samuel Osamu Mayeda, MD

NPI 1487716544ActiveIndividual· Specialist· Orange, CA

Specialist (MD) in Orange, California, licensed in CA, with an NPI issued in December 2006. Their prescriptions cost Medicare Part D more than their services did: $4,511,090 for 4,857 claims, against $115,142 paid for services in 2024. Novartis Pharmaceuticals Corporation was the largest of 18 companies reporting payments in 2025, $550.65 in all, mostly food and beverage.

Overview

NPI1487716544
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedDec 15, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Specialist Primary174400000XC36879CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (CA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients185
Services billed2,400 across 21 procedure codes
Paid by Medicare$115,142

Part D prescriptions in 2024

Prescriptions (claims)4,857 · 11,739 30-day fills
Patients216
Total drug cost$4,511,090
Generic share72% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$550.65 · 23 payments from 18 companies
  • 2024$964.61 · 53 payments from 18 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$550.65 · 23 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Specialist providers in Orange

All Specialist providers in California →